Adaptive versus continuous subthalamic nucleus deep brain stimulation for people with Parkinson's
Official title: Randomized Controlled Trial Comparing Adaptive Versus Continuous Subthalamic Nucleus Deep Brain Stimulation in Parkinson's Disease
Run by Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) · NCT06909045 · Data updated 2026-11-12
This project will try adaptive DBS versus regular continuous DBS in people with Parkinson's who already have Medtronic Percept STN implants to see if one gives more daily ON time without troublesome dyskinesia over six months.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 130 (estimated) |
| Sponsor | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) Academic / other |
| Locations | 4 sites (Leuven and 3 other locations) |
| Status | Recruiting |
| Started | January 27, 2026 |
| Main results expected | February 1, 2027 |
| Study ends | February 1, 2027 |
| Registry record updated | January 29, 2026 |
| Trial ID | NCT06909045 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults with idiopathic Parkinson's who already have bilateral Medtronic Percept PC/RC STN electrodes, a reliable beta peak in at least one STN, can recognize ON/OFF motor states, speak Dutch, and can give informed consent.
✕Probably not a fit
Patients without a Percept device or a detectable beta signal, those with cognitive impairment or dementia, those unable to distinguish motor ON/OFF states, pregnant individuals, or those unable to attend required site visits are unlikely to benefit from participation.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This randomized, multicenter trial compares adaptive deep brain stimulation (aDBS) with standard continuous DBS (cDBS) in people with Parkinson disease who already have bilateral Medtronic Percept PC/RC electrodes targeting the subthalamic nucleus. Participants are programmed to cDBS at the first post-programming visit, then randomized 1:1 to remain on cDBS or switch to aDBS two weeks later, with follow-up visits at three and six months. Patients complete PD home diaries at baseline, two weeks, three months, and six months to measure daily ON time without troublesome dyskinesia, the primary outcome. Study sites include Amsterdam UMC (AMC-UvA), Maastricht UMC+, and UZ Leuven.
Why it matters
Potential benefit: If successful, adaptive DBS could increase daily ON time without troublesome dyskinesia and reduce unnecessary stimulation, improving symptom control and possibly extending device battery life.
How similar studies have gone: Small pilot and crossover studies of aDBS have shown promising reductions in dyskinesia and stimulation time, but larger randomized, longer-duration comparisons remain limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Diagnosis of idiopathic PD based on the UK Brain Bank criteria (Hughes et al. 1992); * Age older than 18 years; * Previous implantation of Medtronic PerceptTM PC/RC DBS electrodes bilateral targeting the STN; * Optimal contact point compatible with aDBS in at least one STN; * Reliable beta peak in at least one STN; * Able to provide informed consent and comply with the study protocol; * Understand the Dutch language. Exclusion Criteria: * Legally incompetent adults; * Patients with ongoing participation in other clinical trials involving neurological interventions; * Inability to recognize the difference between the motor ON or OFF state; * Mild cognitive impairment or dementia; * Pregnancy.
Where it's running
-
Amsterdam UMC
Amsterdam, Netherlands Recruiting -
UZ Leuven
Leuven, Belgium Not yet recruiting -
Maastricht UMC+
Maastricht, Netherlands Not yet recruiting -
HagaZiekenhuis
The Hague, Netherlands Not yet recruiting
Study contacts
- Principal investigator: Martijn Beudel, MD, PhD — Amsterdam UMC
- Study coordinator: M. Beudel, MD, PhD
- Email: closepd@amsterdamumc.nl
- Phone: +31 20 566 9111
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
How physical activity might help people with Parkinson’s disease who have DBS-STN implants
This study tests whether adding regular physical activity can help people with Parkinson’s who have DBS-STN stimulation by trying a structured physiotherapy approach alongside standard care.
-
Patterned deep brain stimulation delivered at home for Parkinson's
This study will test whether three types of patterned deep brain stimulation can be used safely and comfortably at home in people with Parkinson's who already have stable bilateral STN or GPi Boston Scientific DBS systems.
-
Mediterranean diet for managing weight and body composition after bilateral subthalamic nucleus deep brain stimulation in Parkinson's disease
It will see if following a Mediterranean diet for three months after bilateral subthalamic nucleus deep brain stimulation helps adults with Parkinson's control weight and improve body composition.
-
Frequency-specific stimulation of subthalamic nucleus subregions to improve inhibitory control in Parkinson's disease
This tests whether stimulating different parts of the subthalamic nucleus at low (5 Hz) or high (130 Hz) frequencies can improve inhibitory control in people with Parkinson's disease who have deep brain stimulation.
-
How deep brain stimulation affects thinking and memory in Parkinson's
This project will use MRI scans to see if subthalamic nucleus deep brain stimulation (DBS) changes brain networks and relates to thinking or memory declines in people with Parkinson's disease who already have DBS implants.
-
Advanced brain imaging for improving deep brain stimulation in Parkinson's and essential tremor patients
This study is testing if advanced brain imaging can help doctors place and program deep brain stimulation better for people with Parkinson's disease and essential tremor to improve their movement.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.